Vericel Corporation (VCEL)
NASDAQ: VCEL · Real-Time Price · USD
42.53
-0.44 (-1.02%)
At close: Oct 23, 2026, 4:00 PM EDT
42.53
0.00 (0.00%)
After-hours: Oct 23, 2026, 4:10 PM EDT
Vericel Market Cap
Vericel has a market cap or net worth of $2.18 billion as of October 23, 2026. It is the 6,173rd most valuable company in the world and the 1,697th biggest in the United States. Its market cap has increased by 18.47% in one year.
Market Cap
2.18B
Enterprise Value
2.11B
1-Year Change
18.47%
Global Rank
Country Rank
#1,697 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Vericel's market cap has increased from $31.90M to $2.18B, an increase of 6,727.01%. That is a compound annual growth rate of 16.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 2.18B | 19.58% |
| Dec 31, 2025 | 1.82B | -32.80% |
| Dec 31, 2024 | 2.71B | 59.48% |
| Dec 29, 2023 | 1.70B | 36.63% |
| Dec 30, 2022 | 1.24B | -32.39% |
| Dec 31, 2021 | 1.84B | 31.15% |
| Dec 31, 2020 | 1.40B | 80.38% |
| Dec 31, 2019 | 777.70M | 3.12% |
| Dec 31, 2018 | 754.20M | 296.53% |
| Dec 29, 2017 | 190.20M | 163.07% |
| Dec 30, 2016 | 72.30M | 17.75% |
| Dec 31, 2015 | 61.40M | -15.08% |
| Dec 31, 2014 | 72.30M | 412.77% |
| Dec 31, 2013 | 14.10M | -74.46% |
| Dec 31, 2012 | 55.20M | -21.48% |
| Dec 30, 2011 | 70.30M | -2.77% |
| Dec 31, 2010 | 72.30M | 35.14% |
| Dec 31, 2009 | 53.50M | -20.74% |
| Dec 31, 2008 | 67.50M | -2.17% |
| Dec 31, 2007 | 69.00M | -53.19% |
| Dec 29, 2006 | 147.40M | -32.17% |
| Dec 30, 2005 | 217.30M | 65.88% |
| Dec 31, 2004 | 131.00M | 38.19% |
| Dec 31, 2003 | 94.80M | 321.33% |
| Dec 31, 2002 | 22.50M | -45.78% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aurinia Pharmaceuticals | 2.25B |
| Vera Therapeutics | 2.25B |
| Harmony Biosciences Holdings | 2.23B |
| Agios Pharmaceuticals | 2.22B |
| Recursion Pharmaceuticals | 2.17B |
| Pharvaris | 2.15B |
| Immunome | 2.04B |
| Zymeworks | 2.00B |